Yes, but this depends on a few factors. If you’ve undergone Ozempic and Wegovy treatment from September 2023 onwards, then you might not be eligible for a claim as the FDA approved a new label change for the medications that year. It’s important that you reach out to us so that our team can thoroughly review your case and see if you’re a potential claimant.
If you’ve used these semaglutide medications before the label change in 2023, then there’s an even better chance that you’re eligible for a claim, despite these being FDA-approved medications. The FDA approved Ozempic in 2017, Wegovy in 2021, and Rybelsus in 2019. But during this time, they weren’t able to highlight the fact that semaglutide can result in:
Changes to semaglutide labels can make understanding your eligibility for a claim complicated. Our team can give your case a thorough review so you’ll know immediately whether you’re a potential claimant. Once we check your eligibility, we’ll refer you to an attorney who specializes in cases like these.